- (anti-IFN-aR)
nirsevimab (anti-RSV)
MedImmune, Inc. v. Genentech, Inc. "12
years on,
Astra draws a line
under Medimmune". Evaluate.com. 2019-02-14. Retrieved...
-
Cambridge Antibody Technology (in 2006),
MedImmune (in 2007),
Spirogen (in 2013) and
Definiens (by
MedImmune in 2014). It has its
research and development...
-
patents cover Medimmune's processes for
generating the
collections of
human antibody genes that
comprise MedImmune Cambridge libraries.
MedImmune has patents...
-
Tetra in the
European Union.
FluMist was
first introduced in 2003 by
MedImmune. In the
United States,
FluMist is
approved for self- or caregiver-administration...
-
MedImmune, Inc. v. Genentech, Inc., 549 U.S. 118 (2007), was a
decision by the
Supreme Court of the
United States involving patent law. It
arose from...
-
actual controversy was most
recently addressed by the
Supreme Court in
MedImmune, Inc. v. Genentech, Inc., 549 U.S. 118 (2007). But even if an
actual controversy...
- capsule". Daily
Med. 4
March 2022.
Retrieved 16
December 2022. "Zegerid OTC-
omeprazole and
sodium bicarbonate capsule,
gelatin coated". Daily
Med. 5 December...
- Wuxi City. That year WuXi
AppTec also
entered into a
joint venture with
MedImmune, the
biologics arm of AstraZeneca, to co-develop MEDI5117, an anti-IL6...
-
Retrieved 16
August 2023. "Diprivan-
propofol injection, emulsion". Daily
Med.
Retrieved 17
April 2021. "Propofol". The
American Society of Health-System...
-
monoclonal antibody designed for the
treatment of cancer. It was
developed by
MedImmune, and
trialed for use in
glioblastoma and non-small cell lung cancer. Development...
